Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METHOD FOR THE PREPARATION OF CHIRAL HYDROXY ESTERS BY ENZYME/METAL MULTI-CATALYSIS
Document Type and Number:
WIPO Patent Application WO/2004/039998
Kind Code:
A1
Abstract:
The invention provides a process for preparing a chiral hydroxy ester by reacting a compound having botha ketone group and an acyloxy group in a molecule with a hydrogen donor which reduces the ketone group into an hydroxyl group; a metal complex, which catalyzes both the reduction of the ketone and racemization reaction of produced hydroxy group; and an enzyme, which catalyzes enantioselective acyl transfer in anorganic solvent.

Inventors:
KIM MAHN-JOO (KR)
PARK JAI-WOOK (KR)
HAN MIN-YOUNG (KR)
CHOI MIN-YOUNG (KR)
CHOI YOON-KYUNG (KR)
LEE JAE-KWAN (KR)
Application Number:
PCT/KR2003/001437
Publication Date:
May 13, 2004
Filing Date:
July 21, 2003
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
POSTECH FOUNDATION (KR)
KIM MAHN-JOO (KR)
PARK JAI-WOOK (KR)
HAN MIN-YOUNG (KR)
CHOI MIN-YOUNG (KR)
CHOI YOON-KYUNG (KR)
LEE JAE-KWAN (KR)
International Classes:
C12P7/62; C12P41/00; (IPC1-7): C12P41/00
Foreign References:
US5886213A1999-03-23
US20020156300A12002-10-24
US5625030A1997-04-29
US5216015A1993-06-01
Attorney, Agent or Firm:
Lee, Young-pil (1571-18 Seocho-don, Seocho-gu Seoul 137-874, KR)
Download PDF:
Claims:
What is claimed is:
1. A process for preparing a chiral hydroxy ester comprising: mixing a substrate compound having both a ketone group and an acyloxy group in a molecule with a hydrogen donor which reduces the ketone group into an hydroxy group, a metal complex, which catalyzes both the reduction of the ketone into the hydroxy group and the racemization of produced hydroxy group, and an enzyme which catalyzes enantioselective acyl transfer in an organic solvent; and reacting the mixture.
2. The process of claim 1, wherein the chemical compound having both the ketone and the acyloxy group is represented by Formula 2 and the chiral hydroxy ester is represented by Formula 1 [Formula 1] [Formula 2] wherein Rl and R3 independently represent substituted or unsubstituted Cis alkyi group, substituted or unsubstituted Clls alcenyl group, substituted or unsubstituted Ci. is alkynyl group, substituted or unsubstituted Ceis aryl group, substituted or unsubstituted CI15 heteroaryl group, substituted or unsubstituted C4 l5 cycloaLkyl group, substituted or unsubstituted C4l5 heterocycloalkyl group, or substituted or unsubstituted C2 l5 heteroarylalkyl group; R2 represents substituted or unsubstituted C115 alkylene group, substituted or unsubstituted C6 l5 arylene group, substituted or unsubstituted C415 heteroarylene group, substituted or unsubstituted C4l5 cycloalkylene group, substituted or unsubstituted C415 heterocycloalkylene group, or substituted or unsubstituted C2l5 heteroarylalkylene group; and R1 and R2, R2 and R3, Ri and R3 may be linked to each other.
3. The process of claim of 2, wherein the compound of the Chemical Formula 2 is represented by Formula 4 or 5 [Fonnula 4] [Formula 5] wherein R4 represents an Cio alkyi group or an alkyl group substituted with heteroatoms; Rs represents Cl s alkyl group, C25 alkenyl group, C25 alkynyl group; m represents an integer between 1 to 6; X represents halogen atom, C15 alkyl group, C25 alkenyl group, Cl 5 alkoxy group, nitro group, amide group, sulfonyl group or more than one thioalkoxy group; and represents C6 l0 aryl group or CI10 heteroaryl group.
4. The process of claim 1, wherein the metal complex is a ruthenium complex as represented by Formula 3. [Formula 3] wherein Yl, Y2, Y3, Y4, Y5, Y6, Y7 and Y8 each independently represent substituted or unsubstituted Ciio alkyi group, substituted or unsubstituted C6 l5 aryl group, substituted or unsubstituted Ciis heteroaryl group.
5. The process of claim 4, wherein Yl to Ys of the ruthenium complex are all phenyl or methyl group.
6. The process of claim 1, wherein the amount of the metal complex represented by the Formula 3 is 0.01 to 0.05 mol per 1 mol of the substrate used.
7. The process of claim 1, wherein the reaction of the mixture is carried out at a temperature of 0 to 100°.
8. The process claim of 1, wherein the hydrogen donor is selected from the group consisting of hydrogen, formic acid and alcohol of Formula 6 [Formula 6] wherein R'and R"each independently represent straightchained, or branched Ciio alkyl group, C6 15 aryl group, or Cl l5 heteroaryl group.
9. The process of claim 8, wherein the hydrogen donor is supplied at atmospheric pressure.
10. The process of claim 1, wherein the enzyme is a lipase selected from the group consisting of Pseudomonas cepacia lipase (LPS), Candida antartica lipase (CAL) and Candida rugosa lipase (CRL).
Description:
METHOD FOR THE PREPARATION OF CHIRAL HYDROXY ESTERS BY ENZYME/METAL MULTI-CATALYSIS Technical Field The invention relates to a method for preparing chiral hydroxy esters, particularly, to a process for preparing chiral hydroxy esters with high optical purities by combining an enzyme and a metal catalyst in a single reaction chamber and inducing multi-step catalytic reactions.

Background Art Much effort was focused on the developing new methods for stereoselective synthesis of optically active compounds with high optical purities. Among them, two methods are well studied and applied; one is kinetic resolution, utilizing an enzyme catalyst and the other is asymmetric synthesis, utilizing. a metal catalyst. (Wong, C.

H.; Whitesides, G. M. Enzymes in Synthetic Organic Chemistry; Pergamon : Oxford, U.

K., 1994; Noyori, R. , Asymmetric Catalysts in Organic Synthesis; Wiley : New York, 1994).

The kinetic resolution has some advantages-high optical purity of the end product, low unit cost of the enzyme catalyst, and simple reaction condition-and one apparent disadvantage that the yield is less than 50%. On the other hand, the asymmetric synthesis leads high optical purity and yield, but causes the increase of production cost due to the use of expensive chiral reagents. Also, the reaction conditions are complicated.

Recently, a new method that combines an enzyme catalyst and a metal catalyst, has been introduced. (Persson, B. A.; Larsson, A. L. E.; Ray, M. L.; Baclcvall, J. -E. J.

Am. Cheyn. Soc. 1999, 121, 1645.; Lee, D. H.; Huh, E. A.; Kim, M. -J.; Jung, H. M.; Koh, J. H.; Park, J. , Org. Lett. 2000,2, 2377) for the dynamic kinetic resolution of racemic alcohols. According to dynamic kinetic resolution, an enzyme, as an enantioselective acylation catalyst is used with a metal catalyst as a racemization catalyst to produce single enantiomer from a racemic mixture. The yields of the products by this method are higher than those by optical resolution that uses enzyme catalysts only. Furthermore, this method is cost effective compared to the asymmetric synthesis that uses expensive chiral reagents.

It was also reported that ketones were successfully transformed to optically

pure esters by the combination of an enzyme and a metal catalyst. (Jung, H. M.; Koh, J.

H.; Kim, M. -J.; Park, J. , Org. Lett. 2000,2, 409; Jung, H. M.; Koh, J. H.; Kim, M. -J.;<BR> Park, J. , Org Lett. 2000,2, 2487). In this reaction, an excessive amount of acyl donor is used to increase yields. However, the excessive use of acyl donor increases the production cost and makes the separation of required product difficult because the acyl donor remains unreacted in a large portion and has similar polarity with that of product.

Disclosure of Invention The invention provides a process for synthesizing chiral hydroxy esters with high optical purity and high yield from ketones by the combination of an enzyme catalyst and a metal catalyst without additional acyl donors, thereby resolving the problem caused by the use of excessive acyl donors.

In detail, the invention provides a process for preparing chiral hydroxy esters by reacting a compound having both a ketone group and an acyloxy group in a molecule; a hydrogen donor which reduces the ketone into a hydroxy group; a metal complex, which catalyzes both the reduction of the ketone group and racemization of produced hydroxy group; and an enzyme, which catalyzes enantioselective acyl transfer in a suitable organic solvent.

Formula 1 represents the chiral hydroxy ester. Formula 2 represents the substrate compound having both a ketone and an acyloxy group.

[Formula 1] [Formula 2] wherein Ri and R3 independently represent substituted or unsubstituted Cl ls alkyl

group, substituted or unsubstituted Cl l5 akenyl group, substituted or unsubstituted CI-15 alkynyl group, substituted or unsubstituted C6-15 aryl group, substituted or unsubstituted Cl-15 heteroaryl group, substituted or unsubstituted C4-15 cycloalkyl group, substituted or unsubstituted &num 4-15 heterocycloalkyi group or substituted or unsubstituted C2-15 heteroarylalkyl group.

R2 represents substituted or unsubstituted Cl ls alkylene group, substituted or unsubstituted C6-15 arylene group, substituted or unsubstituted C4-15 heteroarylene group, substituted or unsubstituted C4-ls cycloalkylene group, substituted or unsubstituted C4-15 heterocycloalkylene group, or substituted or unsubstituted C2-ls heteroarylalkylene group. Ri and R2, R2 and R3, Rl and R3 may be linked to each other.

In one embodiment, the metal complex is a ruthenium complex represented by Formula 3.

[Formula 3] wherein Y1, Y2, Y3, Y4, Y5, Y6, Y7 and Y8 each independently represent substituted or unsubstituted C1-10 alkyl group, substituted or unsubstituted C6 ls aryl group, substituted or unsubstituted Cl-15 heteroaryl group.

Best mode for carrying out the Invention The above and other features and advantages of the present invention will become more apparent by describing in detail exemplary embodiments thereof.

In the present invention, a chiral hydroxy ester is prepared by multi-step catalytic reactions in which an enzyme and a metal complex are used to induce asymmetrical reduction and transformation reaction.

Specifically, the following are mixed to form a substrate: a substrate having both ketone group and acyloxy group as represented by Formula 2; a ruthenium complex as represented by Formula 3, which reduces the ketone group and catalyzes the racemization of hydroxyl group; a hydrogen donor to reduce the ketone group; and an

enzyme that catalyzes enantioselective acylation of one enantiomer of the racemic alcohols obtained by the racemization of hydroxyl group.

Then, the mixture is soaked in a solvent, deoxygenated by purging with inert gas, and agitated at 0 to 100° C to complete the reaction. The reacted mixture is worked-up and purification process provides optically pure hydroxy ester of Formula 1.

[Formula 1] [Formula 2] wherein R1 and R3 are independently selected from the group consisting of substituted or unsubstituted &num 1-15 alkyi group, substituted or unsubstituted Cl ls akenyl group, substituted or unsubstituted CI-15 alkynyl group, substituted or unsubstituted C6-15 aryl group, substituted or unsubstituted C4-15 heteroaryl group, substituted or unsubstituted C4-ls cycloalkyl group, substituted or unsubstituted C4-15 heterocycloalkyl group and substituted or unsubstituted C2-15 heteroarylalkyl group.

R2 is selected from the group consisting of substituted or unsubstituted CI-15 alkylene group, substituted or unsubstituted C6-15 arylene group, substituted or unsubstituted CI-15 heteroarylene group, substituted or unsubstituted C4-15 cycloalkylene group, substituted or unsubstituted C4-15 heterocycloalkylene group, and substituted or unsubstituted Cl ls heteroarylalkylene group.

R1 and R2, R2 and R3, and R1 and R3 may be linked to each other. Examples of linking formation are substituted or unsubstituted fused ring of 7-20 carbon atoms or substituted or unsubstituted hetero fused ring of 5-20 carbon atoms.

[Formula 3]

wherein Yl, Y2, Y3, Y4, Ys, Y6, Y7 and Y8 each independently represent substituted or unsubstituted alkyl group with 1 to 10 carbon atoms, substituted or unsubstituted C6-15 aryl group, substituted or unsubstituted CI-15 heteroaryl group.

The chemical compound of Formula 2 has both ketone and acyloxy groups and is preferably represented by Formulas 4 or 5.

[Formula 4] [Formula 5] wherein R4 represents an Cl-lo allcyl group or an alkyl group with substituted heteroatoms, Rs represents Cl s alkyl group, C2-5 alkenyl group, or C2-5 alkynyl group, m represents an integer between 1 to 6, X represents halogen atom, C1-5 alkyl group, C2 5 alkenyl group, Cl s alkoxy group, nitro group, amide group, sulfonyl group or more than one thioalkoxy group. Further, represents C6-lo aryl group or C1-10 heteroaryl group.

Examples of Formulas 4 and 5 include Formulas 4a through 4d or Formulas 5 a through 5d.

[Formula 4a] [Formula 4b] [Fonnula 4c]

[Formula 4d]

[Formula 5a] [Formula 5b] [Formula 5c] [Fonnula 5d]

The definitions and examples of the terminology used in this invention are described herein below: Examples of unsubstituted &num 1-15 alkyi group include methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amil and hexyl. More than one hydrogen atom in such alkyl group may be substituted with halogen atom, halide, hydroxy group, nitro group, cyano group, amino group, amidino group, hydrazine, hydrazone, carboxyl group, sulfonic acid group, phosphoric acid group, lower alkyl group with 1 to 15 carbon atoms, and lower alkoxy group with 1 to 15 carbon atoms.

The unsubstituted CI-15 alkenyl or unsubstituted Cl ls alkynyl group refers to an alkyl group containing double or triple carbon bonding in the middle or at the end of the chain. Examples thereof include ethylene, propylene, butylene, hexylene and acetylene. More than one hydrogen atom in such alkenyl or alkynyl groups may be substituted with the same substituents as listed for the Ci. is alkyi group.

Examples of the unsubstituted Cl-ls alkylene group include methylene, ethylene, propylene, isobutylene, sec-butylene, pentylen, iso-amilene and hexylene. More than one hydrogen atom in the alkylene group may be substituted with the same substituents as listed for the Cl-15 allcyl group.

The aryl group refers to C6 30 carbocycle aromatic system in one or more ring structure, which may be used solely or in a combination. These rings may be held together by pendant method or fused together. Examples of aryl include phenyl, naphtyl, tetrahydronaphtyl, indenyl and biphenyl. More than one hydrogen atom in these aryl groups may be substituted with the same substituents as listed for the Ci. is alkyl group.

The arylalkyl group is formed when one or more of the hydrogen atoms of the aryl group are substituted with lower alkyl radicals, such as methyl, ethyl or propyl radicals. Examples include benzil and phenylethyl. More than one hydrogen atom in the arylalkyl group may be substituted with the same substituents as listed for the CI-15 alkyl group.

The heteroaryl group refers to a mono-or bicyclic aromatic group which includes 1,2, 3 or 4 heteroatoms chosen from N, O, P and S. Also, the heteroaryl group refers to a mono-or bicyclic aromatic group in which heteroatom is oxidized or alkylated to form an oxide such as N-oxide or a quaternary amine salt. Examples thereof include thienyl, benzothienyl, pyridyl, pyrazinyl, pyramidinyl, pyridazinyl, quinolinyl, quinoxalinyl, imidazolyl, furanyl, benzofuranyl, thiazolyl, isoxazolyl, benzisoxazolyl, benzimidazolyl, triazolyl, pirazolyl, pyrolyl, indolyl, 2-pyridonyl, 4- pyridyl, N-alkyl-2-pyridonyl, pyrazinonyl, pyridazinonyl, pyrimidinonyl, oxazolonyl, corresponding N-oxides (for example, pyridyl N-oxide and quinolinyl N-oxide) and quaternary salts thereof but are not limited only to the ones specified. More than one hydrogen atom in the heteroaryl group may be substituted with the same substituents as listed for the Cl ls alkyl group.

The heteroarylalkyl group refers to a heteroaryl group in which hydrogen atoms are partially substituted with alkyl groups. More than one hydrogen atom in the

heteroarylalkyl group may be substituted with the same substituents as listed for the C alkyl group.

The cycloalkyl group refers to a monocyclic group including 4 to 15 carbon atoms. More than one hydrogen atom in the cycloalkyl group may be substituted with the same substituents as listed for the Cl-ls alkyl group.

The heterocycloalkyl group refers to a monocyclic aromatic group, which includes 1,2, 3 or 4 heteroatoms chosen from N, O, P or S. More than one hydrogen atom in the heterocycloalkyl group may be substituted with the same substituents as listed for the Cl ls alkyl group.

Preferably, the ruthenium complex of the Formula 3 reduces ketone group of the Formula 2 and simultaneously catalyzes the racemization reaction of hydroxyl obtained from the reduction. The complex preferably has a phenyl group or a methyl group in all Y1 to Y8 groups. Also, the amount of the ruthenium complex per 1 mole of the compound of Formula 2 is preferably 0.01 to 0.05 mol. More preferably 0.02 to 0.04 mol. When the amount is less than 0.01 mol, the reaction is excessively slow, and when the amount is greater than 0.05 mol, the production cost of chiral ester is high.

A enzyme, which catalyzes the acyl transfer reaction, is used, and more specifically, lipase is used. Lipase is an enzyme that hydrolizes ester, and selectively acylates one of the enantiomers of the racemic alcohol to produce chiral ester with high optical purity. Examples of such lipase are Pseudomonas cepacia lipase (LPS), Candida arztarctica lipase (CAL) and Candida rugosa lipase (CRL). Immobilized LPS and immobilized CAL B are preferable. The amount of the immobilized lipase is 0.5 to 20 mg per 1 mmol of the substrate, but preferably 1 to 10 mg.

Hydrogen donor reduces the ketone group of Formula 2 to hydroxyl group in the presence of the catalyst of the ruthenium complex of Formula 3. One or more of such hydrogen donor is selected from the group consisting of hydrogen, formic acid, and alcohol of Formula 6.

[Formula 6] wherein R'and R"each independently represent straight-chained, or branched Cl-lo allcyl

group, C6 15 aryl group, or Cl-15 heteroaryl group.

Preferably, the alcohol of Formula 6 has alkyl side-chain not to be affected by enzyme. Examples thereof are 2,4-dimethyl-3-pentanol and 2,6-dimethyl-4-heptanol.

Preferably, hydrogen under the atmospheric pressure is used as the hydrogen donor because of easiness in removal after reaction. The amount of hydrogen donor is preferably 1 to 50 mol per 1 mol of the compound of Formula 2.

It is not necessary to use a particular type of solvent. However, because the yield and enatioselectivity of the product are affected in lipase-catalyzed reaction by solvent, it is preferable to use aprotonic solvent such as benzene, toluene, hexane, tetrahydrofuran, dioxan, C2 l0 dialkyl ether (e. g. , diethyl ether), C3-10 alkylacetate (e. g., ethyl acetate), acetonitrile, acetone, dicloromethane, cloroform, and carbon tetrachloride.

The suitable amount of the solvent is controlled between 0.2 to 0.4 M based on the substrate used.

Although appropriate temperature of the reaction varies depending on the ruthenium catalyst, preferably, the temperature is 50 to 100° C and more preferably 70 to 80° C. At temperature below 50° C, the racemization reaction is slow, but at temperature above 100° C, the enzyme rapidly loses its activity.

Equation 1 illustrates the multi-step reaction of one of the representative examples.

[Equation 1] OH oo¢, OAc thru 0 pH OAc H2 OAc 0 A c I 4a Ru I i I I i Ac-lipase lipase lipase lipase lipase Ac-lipase Ac-lipase Ac-lipase 0 OH OH H2 OH OH Ru Ac-lipase lipase Product Ru I L- ; - _ lil OH OH , H, Ph 0-0 Ph /R u-_H Rffu P h Ru = pPG% Ph Ph\ Ph CO OC Cl oc

The product of the above Equation 1 is useful as an intermediate for chiral medicines such as rivastigmine.

EXAMPLES The following examples are intended to exemplify the claimed invention, and should not be construed as limiting the scope of the claimed invention.

[Example 1] 6mmol of compound of Formula 4,0. 012 mmol of ruthenium complex of Formula 3 (Both Yl and Y are phenyl), and 5 mg of immobilized lipase were mixed with 1.5 ml of toluene. The reaction vessel was deoxygenated and filled with hydrogen gas at atmospheric pressure. The resulting mixture was agitated for 72 hours at room temperature. After the complete reaction, optically pure hydroxy ester of Formula la was obtained by column chromatography.

[Formula la]

[Examples 2 to 8] Using the same method as Example 1, but instead of using the compound of Formula 4, the compounds of Formula 4b to 4d and 5a to 5d, were used to obtain chiral hydroxy esters of Formulas 1b to lh below, respectively.

[Formula lb]

[Formula 1c] [Formula ld] [Formula le] [Formula lf] [Formula 1g]

[Formula 1h]

Table 1 shows the yield and optical purity of chiral esters prepared according to Experiments 1 to 8. The yield was determined by H-NMR and the optical purity was analyzed by High Performance Liquid Chromatography (HPLC) equipped with chiral column.

[Table 1] Substrate Product Yield (%) Optical Purity (%) Example 1 4a la 91 99 Example 2 4b lb 90 98 Example 3 4c lc 92 95 Example 4 4d Id 90 98 Example 5 Sa le 94 93 Example 6 5b If 93 97 Example 7 5c lg 88 89 Example 8 5d 1h 87 99 According to Examples 1 through 8, as Table 1 depicts, the compounds having both ketone and acyloxy groups in a molecule were successfully transformed to optically pure hydroxyl esters in the presence of a ruthenium complex as a reduction and racemization catalyst, lipase as an acyl transfer catalyst, hydrogen gas as a hydrogen donor by multi-step catalytic reactions.

Industrial Applicability According to the invention, chiral hydroxy esters are obtained with high optical purities and yields from substrates with various structures, all having both ketone and acyloxy groups in a molecule. The invention demonstrates that the synthesis of chiral compound by enzyme/metal catalyzed multi-step reaction can be executed in single reaction chamber. The chiral hydroxy ester prepared by the invention is useful as an intermediate compound in production of agricultural chemicals, medicines and natural chemical compounds. In particular, the chiral hydroxy ester of Formula la, prepared by the method according to the invention, is exceptionally useful as an intermediate compound in preparing a medicine such as rivastigmine.